-transparent.png){kind=logo}
The authors have determined the prevalence of antibodies of cofactor dependent anticardiolipin and beta 2-glycoprotein I and lupus anticoagulant and the frequency of false positive VDRL test in systemic lupus erythematosus. The aim of this retrospective study was to assess the presence of these antibodies and symptoms of antiphospholipid syndrome. The serum samples were examined by modified ELISA method for detecting of cofactor dependent anticardiolipin. The antibodies to beta 2-glycoprotein I were examined by ELISA. The lupus anticoagulant and VDRL test were performed by routine laboratory method. The authors have found that 19 of 58 patients with systemic lupus erythematosus had cofactor dependent anticardiolipin, 10 patients had antibodies to beta 2-glycoprotein I and 4 patients had positive VDRL test. 5 of 34 plasma samples were lupus anticoagulant positive. 19 patients with systemic lupus erythematosus had 14 neuropsychiatric disorders, 9 cardiovascular diseases, 7 thrombocytopenia, 6 histories of recurrent abortion and fetal loss, 5 livedo reticularis and 3 thromboembolic events in all of them had detected antibodies to cofactor dependent anticardiolipin, while these complications were diagnosed in 39 anticardiolipin negative patients much more rarely. The results of this retrospective study suggest that significant association exists between the presence of cofactor dependent anticardiolipin and symptoms of antiphospholipid syndrome in systemic lupus erythematosus.
T Pozsonyi, and
G Lakos, and
L Jakab, and
K Baraczka, and
L Jánoskuti, and
M Kleiber, and
S Sipka, and
A Pajor, and
G Szegedi
December 1994,
British journal of rheumatology,
T Pozsonyi, and
G Lakos, and
L Jakab, and
K Baraczka, and
L Jánoskuti, and
M Kleiber, and
S Sipka, and
A Pajor, and
G Szegedi
February 1989,
Zhonghua nei ke za zhi,
T Pozsonyi, and
G Lakos, and
L Jakab, and
K Baraczka, and
L Jánoskuti, and
M Kleiber, and
S Sipka, and
A Pajor, and
G Szegedi
June 2016,
European journal of rheumatology,
T Pozsonyi, and
G Lakos, and
L Jakab, and
K Baraczka, and
L Jánoskuti, and
M Kleiber, and
S Sipka, and
A Pajor, and
G Szegedi
December 1988,
Zhonghua nei ke za zhi,
T Pozsonyi, and
G Lakos, and
L Jakab, and
K Baraczka, and
L Jánoskuti, and
M Kleiber, and
S Sipka, and
A Pajor, and
G Szegedi
September 2000,
International archives of allergy and immunology,
T Pozsonyi, and
G Lakos, and
L Jakab, and
K Baraczka, and
L Jánoskuti, and
M Kleiber, and
S Sipka, and
A Pajor, and
G Szegedi
January 1982,
Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
T Pozsonyi, and
G Lakos, and
L Jakab, and
K Baraczka, and
L Jánoskuti, and
M Kleiber, and
S Sipka, and
A Pajor, and
G Szegedi
September 2006,
Zhonghua yi xue za zhi,
T Pozsonyi, and
G Lakos, and
L Jakab, and
K Baraczka, and
L Jánoskuti, and
M Kleiber, and
S Sipka, and
A Pajor, and
G Szegedi
October 2006,
The Journal of rheumatology,
T Pozsonyi, and
G Lakos, and
L Jakab, and
K Baraczka, and
L Jánoskuti, and
M Kleiber, and
S Sipka, and
A Pajor, and
G Szegedi
January 1983,
Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
T Pozsonyi, and
G Lakos, and
L Jakab, and
K Baraczka, and
L Jánoskuti, and
M Kleiber, and
S Sipka, and
A Pajor, and
G Szegedi
March 1990,
Journal of clinical & laboratory immunology,
